Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond by SPCC will be held at January 29th, 2025 at 6 pm. The Outlook for the HR+/HER2- MBC Treatment Landscape in 2025 and Beyond Live Webinar will focus on the latest advancements and future directions in treating HR+ HER2- metastatic breast cancer (MBC). Experts will […]
People, places, and platforms that support a cancer patient’s journey by SPCC will be held at March 5, 2025, Virtually. This conference focuses on the various people, places, and platforms that support a cancer patient’s journey. It highlights the importance of a comprehensive support network that goes beyond medical treatment. Compassionate healthcare professionals, supportive family […]
Basic skills in "Strategic Leading and Management in the Cancer Care Continuum" by SPCC will be held from March 7-8, 2025 at Milan, Italy. The leadership and management skills in the Cancer Care Continuum are becoming increasingly important for medical and clinical staff, as they must be prepared to address the challenges, dynamics, and complexity […]
Improving care of Early Breast Cancer (EBC) patients in Europe Investigators Meeting by SPCC will be held at Vienna, Austria at 12 March 2025. This activity, supported by Eli Lilly and Company in collaboration with SPCC, was designed to bring together healthcare professionals and innovative organizations to identify gaps in the treatment of Early Breast […]
Breaking barriers: ensuring equal cancer care access for diverse communities by SPCC will be held at March 17, 2025, Virtually. This event focuses on addressing health disparities in cancer care and the importance of achieving health equity for all patients. It highlights the significant impact of social drivers of health such as socioeconomic status, race, […]
"Efficiency implementation in the cancer care continuum: data, metrics and best practices by SPCC" course includes three educational modules. "How to implement efficiency in Cancer Care by SPCC" is one […]
Tackling oncology inequalities: addressing social drivers of health in LMICs and Africa by SPCC will be held on April 7th, 2025, Virtually. The event organized by SPCC focuses on the urgent need for health equity in cancer care, particularly in low- and middle-income countries (LMICs) and Africa. It will address the impact of social determinants […]
From policy frameworks to real-world implementation: a call to action by SPCC will be held on April 16, 2025, Virtually. This comprehensive course includes three educational modules and a live interactive webinar, focusing on key opportunities, challenges, and best practices in Data Policy and Management in Cancer Care. Expert speakers for the course include Pisani […]
The webinar titled "Advances in Breast Cancer: Epidemiology and Early Diagnosis" will be held on September 23, 2025, at 18:00 CEST. Organized by SPCC, this Webinar will provide an overview of the latest developments in breast cancer. Experts will share updated insights on current trends in incidence, risk factors, and global disparities, as well as […]
This webinar provides an in-depth exploration of HER2-positive breast cancer, covering both the pathological and molecular dimensions of the disease. Attendees will gain expert perspectives on the latest developments in tumour biology, molecular profiling, and diagnostic techniques, as well as their influence on clinical decision-making and patient management. The session aims to deliver a clear […]
Digital health and artificial intelligence are reshaping the landscape of clinical care and patient engagement. This session will examine how these technologies are advancing decision-making, enabling more personalized treatment, and enhancing the overall patient experience. Leading experts will offer their insights on current innovations and future developments in this rapidly evolving field. 18.00 - CET […]
The event "Anti-HER2 therapies: biological mechanisms and toxicity management" is a live webinar scheduled for December 4, 2025, at 18:00 CET. This online educational session is focused on breast cancer and will feature experts who will discuss the molecular mechanisms that underpin HER2-targeted treatments and their role in improving patient outcomes, while also providing a […]